| 000 | 01383 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513053618.0 | ||
| 264 | 0 | _c19950105 | |
| 008 | 199501s 0 0 eng d | ||
| 022 | _a0167-6806 | ||
| 024 | 7 |
_a10.1007/BF00689672 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColletta, A A | |
| 245 | 0 | 0 |
_aAlternative mechanisms of action of anti-oestrogens. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _c1994 |
||
| 300 |
_a5-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 1 |
| 650 | 0 | 4 |
_aEstradiol _xphysiology |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xphysiology |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xdrug effects |
| 650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xphysiology |
| 700 | 1 | _aBenson, J R | |
| 700 | 1 | _aBaum, M | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 31 _gno. 1 _gp. 5-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00689672 _zAvailable from publisher's website |
| 999 |
_c7980788 _d7980788 |
||